NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | FSA Store Inc. | 3cd18f96-34f7-3f2c-e063-6294a90a3b7e | 2025-08-19 | Warnings | 1K09F3G675 |
| Julie | LEVONORGESTREL | Julie Products Inc | 2e9784da-2186-a630-e063-6294a90a8493 | 2025-07-14 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Ohm Laboratories Inc. | f3f2a41a-a9af-4d63-81d8-33181d12af40 | 2025-07-04 | Warnings | 5W7SIA7YZW |
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 1K09F3G675 |
| AfterPill | LEVONORGESTREL | Syzygy Healthcare Solutions, LLC PO Box 588, Westport, CT 06880 | 4d284ba4-9cd7-48e4-95b9-cd6d0367bfd1 | 2025-05-01 | Warnings | 5W7SIA7YZW |
| PostDay One-Step | LEVONORGESTREL | Home Health Brands, LLC | 01c8c95c-6fbe-4068-915d-74418a6bb570 | 2025-04-23 | Warnings | 5W7SIA7YZW |
| LUIZZA 1/20 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Xiromed, LLC | 88d90f33-1034-4d27-034f-11d9c441c9e7 | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Morning After Pill | LEVONORGESTREL | Cadence Health Inc | 2fb59f53-d885-9d4a-e063-6394a90a88cc | 2025-04-15 | Warnings | 5W7SIA7YZW |
| EContra One-Step | LEVONORGESTREL | Afaxys Pharma, LLC | 94b23c49-dfba-4a70-ada5-e5c212e703c5 | 2025-04-08 | Warnings | 5W7SIA7YZW |
| Julie | LEVONORGESTREL | Julie Products Inc. | 8fb303ec-3b6a-47ac-9ad9-83ab6f0d6ae8 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| ITHAPPENZ MORNING AFTER | LEVONORGESTREL | Aurohealth LLC | 5ee40793-0121-4b8f-b20d-3178bbe262e2 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| Julie | LEVONORGESTREL | Julie Products Inc. | 8d20510f-a4e8-4d4b-a96a-f0da91785833 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| Econ Morning After | LEVONORGESTREL | Aurohealth LLC | 177daa65-2e7d-4ff4-887e-b927d6ed8825 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | LEADER/ CARDINAL HEALTH 110, INC. | c7d3a74e-37c4-4c49-861c-64ef363d5a53 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Fem Choice morning after | LEVONORGESTREL | Aurohealth LLC | 14051537-9d6c-4f73-a6e9-5eed554bbf65 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| AMAZON BASIC CARE LEVONORGESTREL | LEVONORGESTREL | Amazon.com Services LLC | 10ecae6f-386f-e199-e063-6294a90a680b | 2025-04-04 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.